RE: Revenue recognition.
I had discussed this kind of procedural thing previously with management. My take on this is that most of this $1.3 is already in the 04 numbers but the contract continues thru their clinical trials so we'll continue with Gel revenue from this agreement.
I agree with others that the biggest thing to take from this is the proof of principal of large scale production. That's HUGE.
I imagine news like this is very relevant to re-enforcing the business case for TUNISIA.